NCT02461758View on ClinicalTrials.gov

Trial of High Dose vs. Standard Dose Influenza Vaccine in Inflammatory Bowel Disease Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

June 30, 2018

Study Completion Date

July 31, 2018

Conditions
Inflammatory Bowel Disease (IBD)
Interventions
BIOLOGICAL

Standard dose Influenza vaccine (SDIV)

BIOLOGICAL

High dose influenza vaccine (HDIV)

Trial Locations (1)

53792

University of Wisconsin Hospital & Clinics, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER

NCT02461758 - Trial of High Dose vs. Standard Dose Influenza Vaccine in Inflammatory Bowel Disease Patients | Biotech Hunter | Biotech Hunter